Molecular Partners AG American Depositary Shares (MOLN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Molecular Partners AG American Depositary Shares, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$3.71
−2.60% today
Market cap
$143M
Overall quality
—
Kronos AI 30-day
+5.2%
8 of 8 simulated paths end higher
Molecular Partners AG American Depositary Shares (MOLN) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $143M. It trades at $3.71, down 2.60% today. 2 analysts' average target of $10.00 implies +169.5% from today's price. Kronos AI's 30-day forecast is +5.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $8.00 – $12.00 |
| Analysts | 2 |
| Upside to average | +169.5% |
Kronos AI 30-day forecast
| Expected close | $4.01 (+5.2%) |
| Likely range | +3.0% … +8.4% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.